Literature DB >> 20202892

Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective.

Renato A Bauer1, Jacqueline M Wurst, Derek S Tan.   

Abstract

Existing drugs address a relatively narrow range of biological targets. As a result, libraries of drug-like molecules have proven ineffective against a variety of challenging targets, such as protein-protein interactions, nucleic acid complexes, and antibacterial modalities. In contrast, natural products are known to be effective at modulating such targets, and new libraries are being developed based on underrepresented scaffolds and regions of chemical space associated with natural products. This has led to several recent successes in identifying new chemical probes that address these challenging targets. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202892      PMCID: PMC2878877          DOI: 10.1016/j.cbpa.2010.02.001

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  47 in total

1.  Molecular architecture of the multiprotein splicing factor SF3b.

Authors:  Monika M Golas; Bjoern Sander; Cindy L Will; Reinhard Lührmann; Holger Stark
Journal:  Science       Date:  2003-05-09       Impact factor: 47.728

Review 2.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

3.  Abyssomicin C-A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway.

Authors:  Bojan Bister; Daniel Bischoff; Markus Ströbele; Julia Riedlinger; Andreas Reicke; Falko Wolter; Alan T Bull; Hans Zähner; Hans-Peter Fiedler; Roderich D Süssmuth
Journal:  Angew Chem Int Ed Engl       Date:  2004-05-03       Impact factor: 15.336

Review 4.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

5.  Scaffold composition and biological relevance of screening libraries.

Authors:  Anang A Shelat; R Kiplin Guy
Journal:  Nat Chem Biol       Date:  2007-08       Impact factor: 15.040

6.  Synthesis of diverse lactam carboxamides leading to the discovery of a new transcription-factor inhibitor.

Authors:  Pui Yee Ng; Yuchen Tang; Wendy M Knosp; H Scott Stadler; Jared T Shaw
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 7.  The exploration of macrocycles for drug discovery--an underexploited structural class.

Authors:  Edward M Driggers; Stephen P Hale; Jinbo Lee; Nicholas K Terrett
Journal:  Nat Rev Drug Discov       Date:  2008-07       Impact factor: 84.694

8.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

9.  Quantifying biogenic bias in screening libraries.

Authors:  Jérôme Hert; John J Irwin; Christian Laggner; Michael J Keiser; Brian K Shoichet
Journal:  Nat Chem Biol       Date:  2009-05-31       Impact factor: 15.040

10.  Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog.

Authors:  Lee F Peng; Benjamin Z Stanton; Nicole Maloof; Xiang Wang; Stuart L Schreiber
Journal:  Bioorg Med Chem Lett       Date:  2009-09-25       Impact factor: 2.823

View more
  62 in total

1.  Small-molecule libraries: naturally inspired oligomers.

Authors:  Jeffrey Aubé
Journal:  Nat Chem       Date:  2012-01-24       Impact factor: 24.427

2.  Peptide bicycles that inhibit the Grb2 SH2 domain.

Authors:  Justin S Quartararo; Pianpian Wu; Joshua A Kritzer
Journal:  Chembiochem       Date:  2012-06-11       Impact factor: 3.164

3.  Solid-Phase Synthesis of β-Amino Ketones Via DNA-Compatible Organocatalytic Mannich Reactions.

Authors:  Nam Tran-Hoang; Thomas Kodadek
Journal:  ACS Comb Sci       Date:  2018-01-24       Impact factor: 3.784

Review 4.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

5.  A strategy for the diversity-oriented synthesis of macrocyclic scaffolds using multidimensional coupling.

Authors:  Henning S G Beckmann; Feilin Nie; Caroline E Hagerman; Henrik Johansson; Yaw Sing Tan; David Wilcke; David R Spring
Journal:  Nat Chem       Date:  2013-08-25       Impact factor: 24.427

6.  Modular Synthesis of Novel Macrocycles Bearing α,β-Unsaturated Chemotypes through a Series of One-Pot, Sequential Protocols.

Authors:  Salim Javed; Mahipal Bodugam; Jessica Torres; Arghya Ganguly; Paul R Hanson
Journal:  Chemistry       Date:  2016-04-05       Impact factor: 5.236

7.  Solid-phase synthesis and chemical space analysis of a 190-membered alkaloid/terpenoid-like library.

Authors:  Gustavo Moura-Letts; Christine M Diblasi; Renato A Bauer; Derek S Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-30       Impact factor: 11.205

8.  The transcription factor FOXM1 is a cellular target of the natural product thiostrepton.

Authors:  Nagaratna S Hegde; Deborah A Sanders; Raphaël Rodriguez; Shankar Balasubramanian
Journal:  Nat Chem       Date:  2011-08-21       Impact factor: 24.427

9.  Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box.

Authors:  Kovi Bessoff; Thomas Spangenberg; Jenna E Foderaro; Rajiv S Jumani; Gary E Ward; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 10.  Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.

Authors:  Leah N Makley; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.